Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
8:11
MSNCNBC
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
CNBC’s Angelica Peebles and Merck chairman and CEO Rob Davis join 'Squawk Box' to discuss the FDA's approval of the injectable version of Keytruda, pricing for the new injection, navigating the new vaccine landscape, demand for Merck's vaccines, future of drug pricing, and more.
5 months ago
Pembrolizumab Uses
Pembrolizumab: Monotherapy Versus Combination Therapy | OncLive
Pembrolizumab: Monotherapy Versus Combination Therapy | OncLive
onclive.com
Jun 28, 2018
Just Published: Adjuvant pembrolizumab after resected stage III melanoma led to a 5-year recurrence-free survival of 55.4%, compared with 38.3% in patients treated with placebo. Read more in NEJM Evidence: https://eviden.cc/3x6Wg6l #ESMO22 | The New England Journal of Medicine
0:03
Just Published: Adjuvant pembrolizumab after resected stage III melanoma led to a 5-year recurrence-free survival of 55.4%, compared with 38.3% in patients treated with placebo. Read more in NEJM Evidence: https://eviden.cc/3x6Wg6l #ESMO22 | The New England Journal of Medicine
FacebookThe New England Journal of
2K viewsSep 10, 2022
Patients with stage III or IV melanoma can benefit from adjuvant pembrolizumab. Whether outcomes with neoadjuvant plus adjuvant pembrolizumab would be better than those with adjuvant therapy alone is unknown. New research findings are summarized in a short video. https://nej.md/3YaD6qN | The New England Journal of Medicine
2:14
Patients with stage III or IV melanoma can benefit from adjuvant pembrolizumab. Whether outcomes with neoadjuvant plus adjuvant pembrolizumab would be better than those with adjuvant therapy alone is unknown. New research findings are summarized in a short video. https://nej.md/3YaD6qN | The New England Journal of Medicine
FacebookThe New England Journal of
2.4K viewsMar 2, 2023
Top videos
Keytruda TV Spot, 'Teresa: Family'
1:30
Keytruda TV Spot, 'Teresa: Family'
iSpot.tv
May 12, 2021
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
1:25
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
MSNCNBC
Nov 19, 2024
8 key drug patents expiring soon — and what it means for the market
8 key drug patents expiring soon — and what it means for the market
qz.com
11 months ago
Pembrolizumab Side Effects
Dr. Machiels on Toxicities with Pembrolizumab for Head and Neck Cancer | OncLive
Dr. Machiels on Toxicities with Pembrolizumab for Head and Neck Cancer | OncLive
onclive.com
Jun 20, 2017
Effets secondaires de Keytruda (pembrolizumab), interactions, utilisations et empreinte thérapeutique - Santé 2026
Effets secondaires de Keytruda (pembrolizumab), interactions, utilisations et empreinte thérapeutique - Santé 2026
oldmedic.com
Sep 2, 2019
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer | OncLive
Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer | OncLive
onclive.com
Dec 22, 2022
Keytruda TV Spot, 'Teresa: Family'
1:30
Keytruda TV Spot, 'Teresa: Family'
May 12, 2021
iSpot.tv
Injectable version of cancer drug Keytruda works as well as current IV form: Merck
1:25
Injectable version of cancer drug Keytruda works as well as current …
Nov 19, 2024
MSNCNBC
8 key drug patents expiring soon — and what it means for the market
8 key drug patents expiring soon — and what it means for the market
11 months ago
qz.com
FDA approves new melanoma drug
1:26
FDA approves new melanoma drug
Sep 5, 2014
CBS News
Merck Announces the U.S. Food and Drug Administration Approves KEYTRUDA (Pembrolizumab and Berahyaluronidase Alfa-Pmph) and KEYTRUDA QLEX
Merck Announces the U.S. Food and Drug Administration Approves KE…
1 month ago
marketscreener.com
Early free access to ‘miracle drug’ Keytruda blocked, cancer groups say news ‘gutting’
1:56
Early free access to ‘miracle drug’ Keytruda blocked, cancer groups …
Aug 4, 2024
NZ HeraldMelissa Nightingale
A Sydney father has made a remarkable recovery from advanced lung cancer with the help of a new immunotherapy drug, Keytruda. #9News | Nightly at 6.00pm | 9 News Sydney
2:35
A Sydney father has made a remarkable recovery from advanc…
11.4K viewsDec 26, 2020
Facebook9 News Sydney
0:53
"I’m getting stronger every day. This therapy has given me a new windo…
2.1K viewsApr 15, 2019
FacebookThe Mesothelioma Center
1:22
Great news! Keytruda, a promising immunotherapy drug, proves effec…
2K viewsNov 6, 2018
FacebookThe Mesothelioma Center
1:45
Here's a Look at Keytruda, the Drug Jimmy Carter Says Made His Tum…
Dec 7, 2015
NBC NewsMaggie Fox
Cancer research
Dec 2, 2022
dailytelegraphJane Hansen
Formycon Secures First Marketing Partnership for Keytruda Biosimilar
3 months ago
marketscreener.com
US FDA approves Merck's injectable version of blockbuster cancer ther…
6 months ago
marketscreener.com
US FDA approves Merck's injectable version of blockbuster cancer ther…
6 months ago
marketscreener.com
This experimental lung cancer drug outperforms blockbuster medicin…
Sep 20, 2024
theprint.in
Merck share price rises on huge Keytruda sales
Feb 1, 2024
ig.com
FDA Approves Merck's KEYTRUDA To Treat High-Risk Early-Stage Tri…
Jul 27, 2021
nasdaq.com
Previous Coalition ‘chose to do nothing’ despite receiving advice f…
Feb 2, 2024
adelaidenow.com.auAndrew Koubaridis
Mark Butler provides update on 60-day scripts during Question Time
Dec 1, 2023
adelaidenow.com.auAndrew Koubaridis
1:51
Keytruda, the cancer drug that has successfully treated melanoma, i…
27.1K viewsJul 23, 2019
Facebook9 News Melbourne
5:12
Will Trump tariffs boost U.S. manufacturing?
10 months ago
CBS NewsMegan Cerullo
TuHURA Biosciences, Inc.: TuHURA Biosciences Initiates Its Phase 3 A…
8 months ago
finanznachrichten.de
What the FDA's hold on three Merck studies means for other drug mak…
6 months ago
thestreet.com
6:41
Summit Therapeutics $SMMT shares nearly doubling this week after its …
2K viewsSep 11, 2024
FacebookCNBC Fast Money
9:40
Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial
Dec 13, 2022
Bloomberg.com
2:52
New cancer drug developed by Chinese firm draws global attention
Mar 16, 2025
cgtn.com
2:03
Life-saving cancer drug could become affordable
3 months ago
7NEWSDigital Team
1:31
Life saving cancer medication Keytruda, could be slashed from $…
7.2K viewsApr 15, 2018
Facebook7NEWS Brisbane
1:32
Merck cancer drug boosts Q4 revenue by 21% year-over-year
Feb 1, 2024
Yahoo
See more videos
Static thumbnail place holder